Director at $AMRK sells 2,600 shares in insider sale

Recently, Moorhead John, a director at $AMRK, made headlines after selling 2,600 shares of the company on 09-15-2025 for an estimated $70,122. This transaction was captured in a recent SEC filing, revealing that John had divested approximately 7.3% of his shares in this particular class of stock. Following this sale, he now retains ownership of 32,974 shares of $AMRK stock.

The insider trading activity at $AMRK has been relatively active, with insiders executing trades on the open market three times in the last six months. Of these transactions, there have been no purchases and three sales. Some notable recent trades include Jess M Ravich selling 25,000 shares for an estimated $662,500, Kathleen Taylor-Simpson, the Chief Financial Officer, selling 5,000 shares for an estimated $103,420, and Moorhead John’s aforementioned sale of 2,600 shares for $70,122.

Moving on to hedge fund activity around $AMRK, 77 institutional investors have opted to add shares of the stock to their portfolios, while 106 have chosen to decrease their positions in the most recent quarter. Some of the significant moves seen include Perritt Capital Management Inc. adding 529,500 shares (+2118.0%) to their portfolio in Q2 2025, which translates to an estimated $11,744,310. Additionally, Flat Footed LLC added 470,180 shares (+inf%) to their portfolio in Q2 2025, totaling an estimated $10,428,592. In contrast, Invesco Ltd. removed 415,519 shares (-79.2%) from their portfolio in Q2 2025, amounting to approximately $9,216,211.

Analysts on Wall Street have been closely monitoring $AMRK, with one firm issuing a “Buy” rating on the stock as of 09/10/2025. Several analysts have also provided price targets for $AMRK in the last six months, with a median target of $31.5. For instance, Michael Baker from DA Davidson set a target price of $29.0 on 09/10/2025, while Lucas Pipes from B. Riley Securities established a target price of $34.0 on 04/29/2025.

It’s important to note that this article serves as an informational piece and does not constitute financial advice. For more detailed information and disclaimers, interested parties can refer to Quiver Quantitative’s disclosures.